< Back to latest news & events

Twitter

The EPO Board of Appeal's recent revocation of the CRISPR-Cas9 patent has brought a lot of attention. However, it's not

March 2020

The EPO Board of Appeal's recent revocation of the CRISPR-Cas9 patent has brought a lot of attention. However, it's not the only CRISPR-related IP issue to watch out for in Europe this year. Read HGF Patent Director @emma_longland article in @IAM_magazine: lnkd.in/d_4f7pk

Latest updates

Fashionably IP - podcast exploring hot topics in the world of fashion and intellectual property

We are delighted to launch our new Fashionably IP Podcast were we will be looking at important hot topics in the world of fashion and intellectual property. In the podcast, …

Read article
Event - 24th June 2022

pro-manchester Trailblazing Tech Conference 2022

pro-manchester is hosting their Trailblazing Tech Conference 2022 on Friday 24th June. At this event, speakers and attendees will be discussing developments in fintech and cyber security, analysing the impact …

Event details

HGF ranked Gold in the FT special report – Europe’s Leading Patent Law Firms 2022

HGF has been ranked in the ‘Gold’ and ‘Silver’ bands in The Financial Times special report ‘Europe’s Leading Patent Law Firms’ published on the 16th June 2022. More than 10,000 …

Read article